Your browser doesn't support javascript.
Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them.
de Laval, Franck; Grosset-Janin, Anaïs; Delon, François; Allonneau, Alexandre; Tong, Christelle; Letois, Flavie; Couderc, Anne; Sanchez, Marc-Antoine; Destanque, César; Biot, Fabrice; Raynaud, Françoise; Bigaillon, Christine; Ferraris, Olivier; Simon-Loriere, Etienne; Enouf, Vincent; Andriamanantena, Dinaherisoa; de Santi, Vincent Pommier; Javelle, Emilie; Mérens, Audrey.
  • de Laval F; SSA (French Military Health Service), CESPA (French Armed Forces Center for Epidemiology and Public Health), Epidemiological Surveillance and Investigations Unit, BdD Marseille-Aubagne, 111 Avenue de la Corse, Marseille, 13568, France. f_de_laval@hotmail.com.
  • Grosset-Janin A; Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France. f_de_laval@hotmail.com.
  • Delon F; SSA (French Military Health Service), 1st Armed Forces Medical Center, Paris, France.
  • Allonneau A; SSA (French Military Health Service), CESPA (French Armed Forces Center for Epidemiology and Public Health), Epidemiological Surveillance and Investigations Unit, BdD Marseille-Aubagne, 111 Avenue de la Corse, Marseille, 13568, France.
  • Tong C; Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France.
  • Letois F; SSA (French Military Health Service), 1st Armed Forces Medical Center, Paris, France.
  • Couderc A; SSA (French Military Health Service), CESPA (French Armed Forces Center for Epidemiology and Public Health), Epidemiological Surveillance and Investigations Unit, BdD Marseille-Aubagne, 111 Avenue de la Corse, Marseille, 13568, France.
  • Sanchez MA; SSA (French Military Health Service), CESPA (French Armed Forces Center for Epidemiology and Public Health), Epidemiological Surveillance and Investigations Unit, BdD Marseille-Aubagne, 111 Avenue de la Corse, Marseille, 13568, France.
  • Destanque C; SSA (French Military Health Service), 1st Armed Forces Medical Center, Paris, France.
  • Biot F; SSA (French Military Health Service), CESPA (French Armed Forces Center for Epidemiology and Public Health), Epidemiological Surveillance and Investigations Unit, BdD Marseille-Aubagne, 111 Avenue de la Corse, Marseille, 13568, France.
  • Raynaud F; SSA (French Military Health Service), 1st Armed Forces Medical Center, Paris, France.
  • Bigaillon C; SSA (French Military Health Service), Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
  • Ferraris O; Direction Générale de l'Armement, Maîtrise NRBC, Vert-le-Petit, France.
  • Simon-Loriere E; SSA (French Military Health Service), Bégin Military Teaching Hospital, Saint-Mandé, France.
  • Enouf V; SSA (French Military Health Service), Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
  • Andriamanantena D; G5 Evolutionary genomics of RNA viruses, Institut Pasteur, Paris, France.
  • de Santi VP; National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, Institut Pasteur, CNRS-UMR 3569, University of Paris, Paris, France.
  • Javelle E; Mutualized Platform of Microbiology, Pasteur International Bioresources Network, Institut Pasteur, Paris, France.
  • Mérens A; SSA (French Military Health Service), Bégin Military Teaching Hospital, Saint-Mandé, France.
BMC Infect Dis ; 21(1): 457, 2021 May 19.
Article in English | MEDLINE | ID: covidwho-1236545
ABSTRACT

BACKGROUND:

This study presents the methods and results of the investigation into a SARS-CoV-2 outbreak in a professional community. Due to the limited testing capacity available in France at the time, we elaborated a testing strategy according to pre-test probability.

METHODS:

The investigation design combined active case finding and contact tracing around each confirmed case with testing of at-risk contact persons who had any evocative symptoms (n = 88). One month later, we performed serology testing to test and screen symptomatic and asymptomatic cases again (n = 79).

RESULTS:

Twenty-four patients were confirmed (14 with RT-PCR and 10 with serology). The attack rate was 29% (24/83). Median age was 40 (24 to 59), and the sex ratio was 15/12. Only three cases were asymptomatic (= no symptoms at all, 13%, 95% CI, 3-32). Nineteen symptomatic cases (79%, 95% CI, 63-95) presented a respiratory infection, two of which were severe. All the RT-PCR confirmed cases acquired protective antibodies. Median incubation was 4 days (from 1 to 13 days), and the median serial interval was 3 days (0 to 15). We identified pre-symptomatic transmission in 40% of this cluster, but no transmission from asymptomatic to symptomatic cases.

CONCLUSION:

We report the effective use of targeted testing according to pre-test probability, specifically prioritizing symptomatic COVID-19 diagnosis and contact tracing. The asymptomatic rate raises questions about the real role of asymptomatic infected people in transmission. Conversely, pre-symptomatic contamination occurred frequently in this cluster, highlighting the need to identify, test, and quarantine asymptomatic at-risk contact persons (= contact tracing). The local lockdown imposed helped reduce transmission during the investigation period.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Contact Tracing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06166-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Contact Tracing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06166-9